Medical Condition News

RSS

Study examines how improvised explosive devices can lead to traumatic brain injury

By accounting for a rush of blood to the head, University of Nebraska-Lincoln engineers have found that blast waves from concussive explosions may put far greater strain on the brain than previously thought.

9 Jun 2015

New research shows that low glycemic index diets reduce autism symptoms in mice

Bread, cereal and other sugary processed foods cause rapid spikes and subsequent crashes in blood sugar. In contrast, diets made up of vegetables, fruits and whole grains are healthier, in part because they take longer to digest and keep us more even-keeled.

9 Jun 2015

Study suggests direct biophysical link between chronic pain, depression and anxiety

Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report.

9 Jun 2015

FDA's Advisory Committee recommends approval of Praluent (alirocumab) Injection

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of the investigational therapy Praluent (alirocumab) Injection.

9 Jun 2015

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.

9 Jun 2015

Lycera forms exclusive global collaboration with Celgene

Lycera Corp., a privately held biopharmaceutical company developing breakthrough immune modulatory medicines, announced today the formation of an exclusive global collaboration with Celgene Corporation to take forward Lycera's proprietary pipeline for cancer and immune-mediated diseases.

9 Jun 2015

Barbara Ann Karmanos Cancer Institute named one of America's Best Hospitals for Cancer Care

The Barbara Ann Karmanos Cancer Institute has received the Women's Choice Award as one of America's Best Hospitals for Cancer Care for 2015. This award signifies Karmanos' commitment and passion towards providing an extraordinary healthcare experience for women and all patients.

9 Jun 2015

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope, the drug discovery and development company focused on disease-modifying treatments that reinstate immune tolerance, announced today that pre-clinical product candidate ATX-F8-117 has been granted Orphan Drug Status by the US Food and Drug Administration for the prevention or treatment of inhibitors in haemophilia A patients with inhibitors or at the risk of producing inhibitors.

9 Jun 2015

Stemedica receives FDA's IND approval for itMSC Phase IIa clinical trial to treat Alzheimer's disease

Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.

9 Jun 2015

Updated My MS Manager mobile phone app helps individuals with MS better manage their disease

My MS Manager, the first-of-its kind mobile phone app created by the Multiple Sclerosis Association of America to help individuals with multiple sclerosis (MS) better manage their disease, now offers new features including a way to connect and share information with one's physician.

9 Jun 2015

Study shows how GLP-1 receptor agonists modify the brain's response to food

Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.

9 Jun 2015

People across the world are living longer but spending more time in ill health

People across the world are living longer but spending more time in ill health as rates of nonfatal diseases and injuries - including diabetes and hearing loss - decline more slowly than death rates, according to a new analysis of 301 diseases and injuries in 188 countries.

9 Jun 2015

New research shows how human immune system could be manipulated to better fight disease

New research from Australian and Singaporean scientists has revealed how immune cell 'spies' are created, providing clues on how the immune system could be manipulated to better fight disease.

9 Jun 2015

Severe restless legs syndrome associated with increased risk of stroke

A new study suggests that increased restless legs syndrome (RLS) severity is associated with subsequent increased risk of stroke.

9 Jun 2015

NGS mutational testing can help detect patients with Barrett's esophagus

Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers.

9 Jun 2015

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

EUROSARC, European Clinical trials in Rare Sarcomas within an integrated translational trial network, has launched a phase II trial of Linsitinib for patients with relapsed and/or refractory Ewing Sarcoma. The trial, EORTC 1225 / OCTO 038, aims to establish pharmacodynamic responses in Ewing sarcoma tumors to Linsitinib using functional imaging and biopsies, and toxicity and clinical outcomes.

9 Jun 2015

UC Davis funds BRAIN-STIM program to uncover potential treatments for neurodegenerative disorders

In 2013, President Obama announced the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, unveiling plans to make a bold investment to understand the human mind with the intent to uncover ways to prevent, treat and cure brain disorders like Alzheimer's, autism, and epilepsy.

9 Jun 2015

Medical Condition News

Study examines how improvised explosive devices can lead to traumatic brain injury

New research shows that low glycemic index diets reduce autism symptoms in mice

Study suggests direct biophysical link between chronic pain, depression and anxiety

FDA's Advisory Committee recommends approval of Praluent (alirocumab) Injection

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Lycera forms exclusive global collaboration with Celgene

Barbara Ann Karmanos Cancer Institute named one of America's Best Hospitals for Cancer Care

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Stemedica receives FDA's IND approval for itMSC Phase IIa clinical trial to treat Alzheimer's disease

Updated My MS Manager mobile phone app helps individuals with MS better manage their disease

Study shows how GLP-1 receptor agonists modify the brain's response to food

People across the world are living longer but spending more time in ill health

New research shows how human immune system could be manipulated to better fight disease

Severe restless legs syndrome associated with increased risk of stroke

NGS mutational testing can help detect patients with Barrett's esophagus

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

UC Davis funds BRAIN-STIM program to uncover potential treatments for neurodegenerative disorders

Weight loss reduces asthma severity in obese adults, finds study

Researchers pinpoint gene that may solve the root cause of diabetes

Glucose-control drug sitagliptin does not raise risk of cardiovascular events

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News